Suppr超能文献

胆管癌干细胞样亚群通过调控相关巨噬细胞形成肿瘤起始微环境。

Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.

作者信息

Raggi Chiara, Correnti Margherita, Sica Antonio, Andersen Jesper B, Cardinale Vincenzo, Alvaro Domenico, Chiorino Giovanna, Forti Elisa, Glaser Shannon, Alpini Gianfranco, Destro Annarita, Sozio Francesca, Di Tommaso Luca, Roncalli Massimo, Banales Jesus M, Coulouarn Cédric, Bujanda Luis, Torzilli Guido, Invernizzi Pietro

机构信息

Center for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Rozzano, Italy.

Center for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Rozzano, Italy.

出版信息

J Hepatol. 2017 Jan;66(1):102-115. doi: 10.1016/j.jhep.2016.08.012. Epub 2016 Sep 1.

Abstract

BACKGROUND & AIMS: A therapeutically challenging subset of cells, termed cancer stem cells (CSCs) are responsible for cholangiocarcinoma (CCA) clinical severity. Presence of tumor-associated macrophages (TAMs) has prognostic significance in CCA and other malignancies. Thus, we hypothesized that CSCs may actively shape their tumor-supportive immune niche.

METHODS

CCA cells were cultured in 3D conditions to generate spheres. CCA sphere analysis of in vivo tumorigenic-engraftment in immune-deficient mice and molecular characterization was performed. The in vitro and in vivo effect of CCA spheres on macrophage precursors was tested after culturing healthy donor cluster of differentiation (CD)14 with CCA-sphere conditioned medium.

RESULTS

CCA spheres engrafted in 100% of transplanted mice and revealed a significant 20.3-fold increase in tumor-initiating fraction (p=0.0011) and a sustained tumorigenic potential through diverse xenograft-generations. Moreover, CCA spheres were highly enriched for CSC, liver cancer and embryonic stem cell markers both at gene and protein levels. Next, fluorescence-activated cell sorting analysis showed that in the presence of CCA sphere conditioned medium, CD14 macrophages expressed key markers (CD68, CD115, human leukocyte antigen-D related, CD206) indicating that CCA sphere conditioned medium was a strong macrophage-activator. Gene expression profile of CCA sphere activated macrophages revealed unique molecular TAM-like features confirmed by high invasion capacity. Also, freshly isolated macrophages from CCA resections recapitulated a similar molecular phenotype of in vitro-educated macrophages. Consistent with invasive features, the largest CD163 set was found in the tumor front of human CCA specimens (n=23) and correlated with a high level of serum cancer antigen 19.9 (n=17). Among mediators released by CCA spheres, only interleukin (IL)13, IL34 and osteoactivin were detected and further confirmed in CCA patient sera (n=12). Surprisingly, a significant association of IL13, IL34 and osteoactivin with sphere stem-like genes was provided by a CCA database (n=104). In vitro combination of IL13, IL34, osteoactivin was responsible for macrophage-differentiation and invasion, as well as for in vivo tumor-promoting effect.

CONCLUSION

CCA-CSCs molded a specific subset of stem-like associated macrophages thus providing a rationale for a synergistic therapeutic strategy for CCA-disease.

LAY SUMMARY

Immune plasticity represents an important hallmark of tumor outcome. Since cancer stem cells are able to manipulate stromal cells to their needs, a better definition of the key dysregulated immune subtypes responsible for cooperating in supporting tumor initiation may facilitate the development of new therapeutic approaches. Considering that human cholangiocarcinoma represents a clinical emergency, it is essential to move to predictive models in order to understand the adaptive process of macrophage component (imprinting, polarization and maintenance) engaged by tumor stem-like compartment.

摘要

背景与目的

一类具有治疗挑战性的细胞,即癌症干细胞(CSCs),是胆管癌(CCA)临床严重程度的原因。肿瘤相关巨噬细胞(TAMs)的存在在CCA和其他恶性肿瘤中具有预后意义。因此,我们推测CSCs可能积极塑造其肿瘤支持性免疫微环境。

方法

将CCA细胞在三维条件下培养以生成球体。对免疫缺陷小鼠体内肿瘤发生植入的CCA球体进行分析并进行分子表征。用CCA球体条件培养基培养健康供体分化簇(CD)14后,测试CCA球体对巨噬细胞前体的体外和体内作用。

结果

CCA球体在100%的移植小鼠中植入,并显示肿瘤起始分数显著增加20.3倍(p=0.0011),并且在不同的异种移植代中具有持续的致瘤潜力。此外,CCA球体在基因和蛋白质水平上均高度富集CSC、肝癌和胚胎干细胞标志物。接下来,荧光激活细胞分选分析表明,在存在CCA球体条件培养基的情况下,CD14巨噬细胞表达关键标志物(CD68、CD115、人类白细胞抗原-D相关、CD206),表明CCA球体条件培养基是一种强大的巨噬细胞激活剂。CCA球体激活的巨噬细胞的基因表达谱揭示了独特的分子TAM样特征,这通过高侵袭能力得到证实。同样,从CCA切除标本中新鲜分离的巨噬细胞概括了体外培养巨噬细胞的相似分子表型。与侵袭特征一致,在人类CCA标本(n=23)的肿瘤前沿发现了最大的CD163集,并且与高水平的血清癌抗原19.9(n=17)相关。在CCA球体释放的介质中,仅检测到白细胞介素(IL)13、IL34和骨激活素,并在CCA患者血清(n=12)中进一步得到证实。令人惊讶的是,CCA数据库(n=104)提供了IL13、IL34和骨激活素与球体干细胞样基因的显著关联。IL13、IL34、骨激活素的体外组合负责巨噬细胞分化和侵袭,以及体内肿瘤促进作用。

结论

CCA-CSCs塑造了一类特定的干细胞样相关巨噬细胞亚群,从而为CCA疾病的协同治疗策略提供了理论依据。

简要概述

免疫可塑性是肿瘤结局的一个重要标志。由于癌症干细胞能够根据自身需要操纵基质细胞,更好地定义负责协同支持肿瘤起始的关键失调免疫亚型可能有助于开发新的治疗方法。鉴于人类胆管癌是一种临床急症,转向预测模型以了解肿瘤干细胞样区室参与的巨噬细胞成分的适应性过程(印记、极化和维持)至关重要。

相似文献

1
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.
J Hepatol. 2017 Jan;66(1):102-115. doi: 10.1016/j.jhep.2016.08.012. Epub 2016 Sep 1.
2
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
J Hepatol. 2021 Jun;74(6):1373-1385. doi: 10.1016/j.jhep.2020.12.031. Epub 2021 Jan 21.
4
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
Liver Int. 2022 Jan;42(1):233-248. doi: 10.1111/liv.15049. Epub 2021 Sep 16.
5
Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
Int J Mol Sci. 2019 Aug 25;20(17):4154. doi: 10.3390/ijms20174154.
6
TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression.
J Hepatol. 2021 Apr;74(4):860-872. doi: 10.1016/j.jhep.2020.11.018. Epub 2020 Nov 19.
7
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.
Sci Rep. 2017 Dec 15;7(1):17667. doi: 10.1038/s41598-017-17804-1.
9
Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression.
Front Immunol. 2024 Sep 3;15:1451474. doi: 10.3389/fimmu.2024.1451474. eCollection 2024.
10
Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma.
Cancer Sci. 2023 Aug;114(8):3230-3246. doi: 10.1111/cas.15812. Epub 2023 Apr 20.

引用本文的文献

1
Applications of 3D models in cholangiocarcinoma.
Front Oncol. 2025 Jul 31;15:1598552. doi: 10.3389/fonc.2025.1598552. eCollection 2025.
3
Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy.
Cells. 2025 May 19;14(10):741. doi: 10.3390/cells14100741.
6
Cancer stem cells and niches: challenges in immunotherapy resistance.
Mol Cancer. 2025 Feb 25;24(1):52. doi: 10.1186/s12943-025-02265-2.
7
The Immune-Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies.
Cancers (Basel). 2025 Jan 15;17(2):272. doi: 10.3390/cancers17020272.
8
The Immune Landscape and Its Potential for Immunotherapy in Advanced Biliary Tract Cancer.
Curr Oncol. 2024 Dec 31;32(1):24. doi: 10.3390/curroncol32010024.
9
Organoids and spheroids: advanced models for liver cancer research.
Front Cell Dev Biol. 2025 Jan 9;12:1536854. doi: 10.3389/fcell.2024.1536854. eCollection 2024.
10

本文引用的文献

1
miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1.
Oncotarget. 2016 May 31;7(22):32421-32. doi: 10.18632/oncotarget.8718.
5
PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma.
Clin Cancer Res. 2016 Jan 15;22(2):470-8. doi: 10.1158/1078-0432.CCR-15-0715. Epub 2015 Sep 15.
6
CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction.
PLoS One. 2015 Jul 15;10(7):e0132703. doi: 10.1371/journal.pone.0132703. eCollection 2015.
7
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.
Oncogene. 2016 Feb 11;35(6):671-82. doi: 10.1038/onc.2015.132. Epub 2015 May 11.
8
Prognostic value of neutrophil distribution in cholangiocarcinoma.
World J Gastroenterol. 2015 Apr 28;21(16):4961-8. doi: 10.3748/wjg.v21.i16.4961.
9
Profiles of cancer stem cell subpopulations in cholangiocarcinomas.
Am J Pathol. 2015 Jun;185(6):1724-39. doi: 10.1016/j.ajpath.2015.02.010. Epub 2015 Apr 17.
10
The interaction of anticancer therapies with tumor-associated macrophages.
J Exp Med. 2015 Apr 6;212(4):435-45. doi: 10.1084/jem.20150295. Epub 2015 Mar 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验